Healthcare Market Research Reports and Trends

The global  vascular closure devices market  is expected to reach USD 984.6 Million by 2022 from USD 704.8 Million in 2017, at a CAGR of 6.9%.  The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the market Vascular closure devices are relatively high-priced devices compared to manual compression devices. The average price of a vascular closure device is about USD 150–USD 250 while that of a manual compression device is about USD 15–USD 25. The cost of VCDs essentially adds up to the patient’s hospitalization bill and even increases the per patient cost for hospitals and simultaneously reduces profits. Moreover, radial artery access makes it more convenient for doctors to achieve hemostasis using simple manual compression methods. Interventional procedures using radial artery access do not generally require vascular closure devices, which is a

Growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes, and growing public awareness about infertility and the available treatment options. However, the high cost and low success rate of the IVF treatment and restrictive regulation and ethical concerns are expected to restrict the growth of market to a certain extent. Rise in consumption of alcohol and cigarettes The growing consumption of alcohol and cigarettes is linked to rising infertility rates among both men and women across the globe. Worldwide alcohol consumption per person aged 15 years or older is 6.2 liters annually. According to the University of Washington’s Institute for Health Metrics and Evaluation, in 2012, 8.2% of all Americans were considered to be heavy drinkers, and 18.3% were binge drinkers in the US. Drinking alcohol affects the reproductive system. Heavy drinking drastically affects a woman’s menstrual cycle and o

Biomaterials Market , Materials (Metallic, Ceramic, Polymers, Natural). Application ( Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology ). Factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases are driving the growth of the market. Emerging markets such as  China, India, and Japan  are the key areas of opportunity for players in this market. However, stringent clinical & regulatory processes and unfavorable healthcare reforms in the  US  are expected to restrain the growth. Increased funds and grants by government bodies and universities for the development of novel biomaterials The demand for and usage of biomaterials in various medical applications has increased significantly across the globe over the last few years. Also, several government

Holography in medical science is mainly used to form 3D images of the human anatomy. Medical 3D holography is used to represent complex 3D structures beneficial for medical imaging, medical research, and medical training & education. The holography products covered in the study include holography displays, holography microscopes, holography prints, holography software, and holoscopes. The overall  medical holography market  is expected to grow from USD 163.4 million in 2015 to USD 953.9 million by 2021, at a  CAGR  of 33.7% from 2016 to 2021. Rising adoption of holography products in biomedical research and medical education drives the growth of the medical holography market. Holography has emerged as one of the most promising tools for the medical industry. Holographic techniques have extended their applications in life sciences and medical research as well as medical education. The use of holographic imaging and projection has resulted in tremendous changes in the field o

Breast Imaging Technologies Market  growth is largely driven by factors such as technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums focusing on spreading awareness about the benefits of early screening and diagnosis. The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. Growing incidence of breast cancer Breast cancer is among the most common cancers affecting women in developed as well as developing countries. According to the American Cancer Society, breast cancer is the second-leading cause of cancer-related deaths in women across the globe. In the US, one in eight women develops invasive breast cancer over the course of her lifetime. According to the American Cancer So

Rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. Risk of adverse cardiovascular events associated with the use of NSAIDs in osteoarthritis treatment is likely to hamper the growth of the market. The  osteoarthritis therapeutics market  is expected to grow from USD 6.8 billion in 2019 to reach USD 10.1 billion by 2024, at a CAGR of 8.1%. Knee segment to witness the highest growth during the forecast period Based on anatomy, the market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment accounted for the largest market share in 2018 and is expected to register the highest CAGR during the forecast period. This is attributed to a large number of patients suffering from knee osteoarthritis. Download PDF Brochure on Osteoarthritis Therapeutics Market Viscosupplementation agents segment to dominate the osteoarthritis therapeutics market in 2018 Based on drug type, the mar

Data privacy concerns and a lack of sufficiently skilled personnel to develop healthcare chatbots also serve to affect market growth to a certain extent. At present, chatbots are adopted among the developed countries such as North and Europe, and is yet to witness widespread adoption in emerging countries, where doctors and other healthcare providers are still reluctant to adopt advanced healthcare solutions. Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=27837519 Rising internet connectivity and smart device adoption drive the market growth Rising Internet connectivity and the growing adoption of smartphones and mobile platforms play a key role in ensuring the adoption and use of chatbots. This has ensured growing numbers of consumers to access healthcare services, and also greatly broadened the reach of said services. According to data published by Anthem Insurance Companies, Inc. (US) in May 2017, around 52% of smartphone users gather heal

The market has witnessed substantial growth in the past few years driven by the increasing incidence of healthcare-associated infections (HAIs), government policies for preventing HAIs, rising healthcare expenditure, and increasing number of surgeries. Market Growth Overview : The  global infection surveillance solutions market  is projected to reach USD 508.8 Million by 2021, at a CAGR of 14.1% from 2016 to 2021.  However, factors such as high cost of software, reluctance among medical professionals to adopt advanced healthcare tools, and dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of the infection surveillance solutions market to a certain extent. Product Overview : On the basis of products, the market is classified into software and services. The software segment is further segmented into on-premise and web-based software. The services included in this report are subdivided into product support & maintenance, traini